To amend title VI of the Federal Food, Drug, and Cosmetic Act to ensure the supply chain transparency needed for companies to make safe cosmetics, and for other purposes.
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, To amend title VI of the Federal Food, Drug, and Cosmetic Act to ensure the supply chain transparency needed for companies to make safe cosmetics, and for other purposes., changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Trade, Labor.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section H5EED2A5ED4F440FD9FD9A1ADBFE45018: 1. Short title This Act may be cited as the Cosmetic Supply Chain Transparency Act of 2023.
- Section H69E2161613E74A43B01123D05C353A68: 2. Cosmetic regulation Chapter VI of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 361 et seq.) is amended— by inserting before section 601 the...
- Section H00CB91CDF2C94BB59D3B6FDE3875959C: 621. Definitions In this subchapter: The term brand owner means the entity responsible for bringing a cosmetic to market. The term flavor or fragrance company...
- Section H26B3E5D80A6A4D039220E210F2CE89C7: 622. Cosmetic and ingredient safety information At the request of a brand owner of a cosmetic, a supplier of the cosmetic or any ingredient therein shall, not...
- Section HC3DC716F58224A39A90F6D0A5A799F86: 623. Process for establishing an FDA list of nonfunctional constituents known or reasonably expected to be present in cosmetics and ingredients The Secretary...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, To amend title VI of the Federal Food, Drug, and Cosmetic Act to ensure the supply chain transparency needed for companies to make safe cosmetics, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Trade, Labor
Primary Purpose
This bill, To amend title VI of the Federal Food, Drug, and Cosmetic Act to ensure the supply chain transparency needed for companies to make safe cosmetics, and for other purposes., changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
IntroducedMs. Schakowsky (for herself, Ms. Norton, Ms. Tlaib, Ms. Velázquez, …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_secretary"
- → The Secretary identified in the operative section
- "the_commission"
- → The commission identified in the operative section
Key Definitions
Terms defined in this bill
a substance or mixture of substances that— is used in the manufacture of a cosmetic for commercial distribution
a substance or mixture of substances that— is used in the manufacture of a cosmetic for commercial distribution
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology